The global human milk oligosaccharides market (HMOs) is expected to grow significantly in terms of value sales, with an estimated value of USD 199 million in 2022 and a projected value of USD 556 million by 2027. The market is expected to experience a compound annual growth rate of 22.7% during the forecast period, which can be attributed to macroeconomic and microeconomic factors witnessed in key countries.
One of the factors driving the market is the rising number of infants globally, which has led to an increase in demand for HMO-based infant formula. Additionally, there is a growing trend of adopting healthy lifestyles by consuming functional food and beverages, which has also boosted the utilization of HMOs in manufacturing.
The growth of online grocery shopping and the introduction of new apps have also contributed to the market's growth, as it has made it more convenient for consumers to purchase HMO-based products. The increase in smartphone usage, dedicated apps, and emerging payment methods has also driven the growth of online grocery shopping, which has consequently impacted the market for consumer products derived from HMOs.
In the functional food manufacturing industry, there is an adoption of advanced technologies, such as high-hydrostatic pressure, ultrasound-assisted and microwave-assisted extraction, pulsed electric field, radio-frequency drying, high voltage electrical discharge, and supercritical fluids. These technologies are being used to minimize the deterioration of sensory, nutritional, and functional food ingredients characteristics.
Moreover, technologies such as encapsulation, nanoencapsulation, and bio-encapsulation have been introduced to drive technological innovations in the functional food ingredients industry. These technologies are being adopted to formulate better-suited and customized food products for consumers to cater to the growing demand.
Key players in the HMO market include DSM, BASF SE, Chr. Hansen Holding A/S, DUPONT, and Royal FrieslandCampina N.V.
Global Human Milk Oligosaccharides (HMO) Market is anticipated to grow considerably in the coming years due to rise in demand for infant nutrition food products.
Human milk oligosaccharides are the complex sugars that are produced in the breast milk by mothers in large quantities.
It prevents the growth of other pathogens in the same environment.The drivers of human milk oligosaccharides market include speedy technological improvements in product line, rise in application in the infant supplements, growing application in food and beverages and increasing use in dairy sector.
Moreover, change in lifestyle, rise in health awareness and rising demand for human milk donors are expected to drive the market growth.
However, low availability of raw materials and high priced chemical and enzymatic synthesis techniques, lack of technical expertise and significant R cost are hampering the market growth.Download Sample Report @ https://www.millioninsights.com/industry-reports/human-milk-oligosaccharides-hmo-market/request-sampleNevertheless, leading players adopting merger& acquisition, affiliations and collaboration strategy and improvements in supply chain management are a few trends in human milk oligosaccharides industry.
Moreover, future investments are expected to bring opportunities for the market players.Human milk oligosaccharides market is categorized on the basis of type, application and geography.
The global human milk oligosaccharides market size is anticipated to reach USD 101.5 million by 2027, according to a new report by Radiant Insights, Inc.
Increasing awareness regarding the functions and health benefits associated with Human Milk Oligosaccharides (HMO) is expected to fuel its demand over the forecast period.
Human milk oligosaccharides in functional food and beverage products and food supplements can help the treatment of certain disorders and high-risk health conditions, which in turn is anticipated to boost the product demand.
As per the United Nations International Children’s Education Fund (UNICE) the under-five mortality rate was one per 11 children in 1990 which dropped to one per 26 children in 2018.
Furthermore, the prebiotic effects of HMOs make them suitable to be use in functional foods and beverages and food supplements.
For instance, in April 2019, Nestlé S.A., a Switzerland-based food and beverage company, introduced three new products in U.K., namely, SMA Advanced Follow-on Formula, SMA Advanced Growing up Milk, and SMA Advanced Infant Formula.
The global Human Milk Oligosaccharides (HMO) Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2021-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the human milk oligosaccharides (HMO) market includes Elicityl S.A., Glycom A/S , Glycosyn LLC, Inbiose NV, Jennewein Biotechnologie GmbH, Medolac Laboratories and ZuChem Inc.. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Human Milk Oligosaccharides (HMO) Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/human-milk-oligosaccharides-hmo-market/download-sampleMarket DynamicsThe increasing awareness regarding HMOs and its benefits of improving immunity and bacterial growth which are essential to human body are driving the market growth.
On the other hand, high production cost associated with HMOs and availability of substitutes such as galactooligosaccharides and fructooligosaccharides may hamper the market growth.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.
These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities.
Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of human milk oligosaccharides (HMO).Browse Global Human Milk Oligosaccharides (HMO) Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/human-milk-oligosaccharides-hmo-marketMarket SegmentationThe broad human milk oligosaccharides (HMO) market has been sub-grouped into product and application.
